CellSeed Inc. (TYO:7776)
155.00
0.00 (0.00%)
Nov 18, 2026, 10:19 AM JST
CellSeed Market Cap
CellSeed has a market cap or net worth of 6.13 billion as of November 17, 2026. It is the 31,629th most valuable company in the world and the 2,851st biggest in Japan. Its market cap has decreased by 55.91% in one year.
Market Cap
6.13B
Enterprise Value
n/a
Revenue
161.00M
Global Rank
Country Rank
#2,851 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since March 16, 2010, CellSeed's market cap has increased from 5.26B to 6.13B, an increase of 16.44%. That is a compound annual growth rate of 0.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 6.13B | -31.74% |
| Dec 30, 2025 | 8.98B | -35.09% |
| Dec 30, 2024 | 13.83B | 62.71% |
| Dec 29, 2023 | 8.50B | 107.22% |
| Dec 30, 2022 | 4.10B | 25.55% |
| Dec 30, 2021 | 3.27B | -13.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Carna Biosciences | 7.48B |
| Kidswell Bio | 7.34B |
| ADR Biomedical Holdings | 7.06B |
| StemCell Institute | 6.44B |
| J-Pharma | 6.38B |
| TMS Co., Ltd. | 6.35B |
| Chiome Bioscience | 6.23B |
| Nano Holdings | 6.19B |